Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Tien-Li LeeCEO | Aardvark TherapeuticsAARD | Open-market buy | 25/12/11 | 25/12/12 | 7,000 sh | $14.49 | $101,430 | +0.5% |
Nelson SunCFO | Aardvark TherapeuticsAARD | Open-market buy | 25/12/11 | 25/12/12 | 3,000 sh | $14.40 | $43,200 | +2.8% |
Aardvark TherapeuticsAARD | Open-market buy | 25/09/15 | 25/09/16 | 10,000 sh2 trades | $9.66avg. | $96,605 | +0.7% | |
Aardvark TherapeuticsAARD | Open-market buy | 25/09/10–25/09/12 | 25/09/12 | 20,000 sh3 trades | $8.03avg. | $160,610 | +1.3% | |
Nelson SunCFO | Aardvark TherapeuticsAARD | Open-market buy | 25/09/09 | 25/09/10 | 6,000 sh | $8.07 | $48,420 | +6.0% |
Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 1,250,000 sh2 trades | $16.00avg. | $20,000,000 | No record | |
Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 187,500 sh | $16.00 | $3,000,000 | +23.4% | |
Bihua ChenOther | Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 187,500 sh | $16.00 | $3,000,000 | +23.4% |
Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 1,250,000 sh2 trades | $16.00avg. | $20,000,000 | No record | |
Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 1,250,000 sh2 trades | $16.00avg. | $20,000,000 | No record | |
Tien-Li LeeCEO | Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 16,542 sh | $16.00 | $264,672 | +1.1% |
Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 1,250,000 sh2 trades | $16.00avg. | $20,000,000 | No record | |
Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 1,250,000 sh2 trades | $16.00avg. | $20,000,000 | No record | |
Nelson SunCFO | Aardvark TherapeuticsAARD | Open-market buy | 25/02/14 | 25/02/19 | 10,000 sh | $16.00 | $160,000 | +11.2% |